DE60230936D1 - Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen - Google Patents

Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen

Info

Publication number
DE60230936D1
DE60230936D1 DE60230936T DE60230936T DE60230936D1 DE 60230936 D1 DE60230936 D1 DE 60230936D1 DE 60230936 T DE60230936 T DE 60230936T DE 60230936 T DE60230936 T DE 60230936T DE 60230936 D1 DE60230936 D1 DE 60230936D1
Authority
DE
Germany
Prior art keywords
estra
benzodioxol
dien
propynyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230936T
Other languages
English (en)
Inventor
Cornelis Sennef
Bernardus B W M M Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of DE60230936D1 publication Critical patent/DE60230936D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60230936T 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen Expired - Lifetime DE60230936D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26

Publications (1)

Publication Number Publication Date
DE60230936D1 true DE60230936D1 (de) 2009-03-05

Family

ID=8181136

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60209248T Expired - Lifetime DE60209248D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen
DE60230936T Expired - Lifetime DE60230936D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60209248T Expired - Lifetime DE60209248D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen

Country Status (27)

Country Link
US (1) US20040266863A1 (de)
EP (2) EP1652526B1 (de)
JP (1) JP4647909B2 (de)
KR (1) KR20050038580A (de)
CN (1) CN100531738C (de)
AT (2) ATE420649T1 (de)
AU (1) AU2002348996B2 (de)
BR (1) BR0213466A (de)
CA (1) CA2463446C (de)
CY (1) CY1110173T1 (de)
DE (2) DE60209248D1 (de)
DK (1) DK1652526T3 (de)
EC (1) ECSP045080A (de)
ES (1) ES2319563T3 (de)
HK (1) HK1087357A1 (de)
HR (1) HRP20040370B1 (de)
HU (1) HUP0500070A3 (de)
IL (2) IL161248A0 (de)
IS (1) IS2702B (de)
MX (1) MXPA04003781A (de)
NO (1) NO332978B1 (de)
NZ (1) NZ532429A (de)
PL (1) PL206687B1 (de)
PT (1) PT1652526E (de)
RU (1) RU2302245C2 (de)
WO (1) WO2003037354A1 (de)
ZA (1) ZA200403088B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
MX2007006045A (es) * 2004-11-19 2007-06-13 Organon Nv Combinacion farmaceutica que comprende inhibidor selectivo de reabsorcion de serotonina y antagonista del receptor de glucocorticoide para tratamiento de depresion.
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス， インコーポレイテッド Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
US8658128B2 (en) 2011-02-03 2014-02-25 Pop Test Cortisol Llc System and method for diagnosis and treatment
EP2699245A4 (de) * 2011-04-18 2014-12-10 Pop Test Cortisol Llc Behandlung von haarausfall
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
DE69835225T2 (de) * 1997-10-06 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
DK1370268T3 (da) * 2001-03-23 2009-09-14 Corcept Therapeutics Inc Fremgangsmåde til behandling af stresssygdomme under anvendelse af glucocorticoid-receptor-specifikke antagonister
JP2005512949A (ja) * 2001-05-04 2005-05-12 コーセプト セラピューティクス， インコーポレイテッド グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法
IL160649A0 (en) * 2001-08-31 2004-07-25 Corcept Therapeutics Inc Methods for inhibiting cognitive deterioration in adults with down syndrome

Also Published As

Publication number Publication date
HUP0500070A2 (hu) 2005-04-28
ES2319563T3 (es) 2009-05-08
CA2463446A1 (en) 2003-05-08
CA2463446C (en) 2010-02-23
ATE420649T1 (de) 2009-01-15
IL161248A0 (en) 2004-09-27
BR0213466A (pt) 2004-11-09
CN100531738C (zh) 2009-08-26
NZ532429A (en) 2004-10-29
US20040266863A1 (en) 2004-12-30
RU2004116082A (ru) 2005-05-10
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
KR20050038580A (ko) 2005-04-27
CY1110173T1 (el) 2015-01-14
EP1441739B1 (de) 2006-02-15
HRP20040370B1 (en) 2012-09-30
AU2002348996B2 (en) 2008-06-05
EP1652526B1 (de) 2009-01-14
IS7204A (is) 2004-03-31
PL206687B1 (pl) 2010-09-30
MXPA04003781A (es) 2004-07-30
JP2005521637A (ja) 2005-07-21
EP1441739A1 (de) 2004-08-04
NO332978B1 (no) 2013-02-11
DE60209248D1 (de) 2006-04-20
JP4647909B2 (ja) 2011-03-09
ECSP045080A (es) 2004-06-28
PT1652526E (pt) 2009-02-06
IL161248A (en) 2010-12-30
HK1087357A1 (en) 2006-10-13
DK1652526T3 (da) 2009-05-18
WO2003037354A1 (en) 2003-05-08
CN1582153A (zh) 2005-02-16
PL369261A1 (en) 2005-04-18
HUP0500070A3 (en) 2012-09-28
ATE317700T1 (de) 2006-03-15
HRP20040370A2 (en) 2004-08-31
ZA200403088B (en) 2005-01-24
IS2702B (is) 2010-11-15
EP1652526A3 (de) 2006-08-02
EP1652526A2 (de) 2006-05-03

Similar Documents

Publication Publication Date Title
NO20042811L (no) Substituerte henzoksazoler og analoger som estrogene midler
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
ATE269336T1 (de) Steroidrezeptor-modulator verbindungen und methoden
HK1087357A1 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
DK0806952T3 (da) Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
DK1487859T3 (da) Fremstillingsmetoder til at fremstille Eplerenon
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
AR018313A1 (es) Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
DE60006948T2 (de) Antagonismus des estrogen-rezeptors-beta und knochenkrankheiten
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
NO974256L (no) Anvendelse av anti-östrogener som befruktningshindrende midler for menn
DK1090028T3 (da) Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1652526

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAELTE,